Nicole Lemerond
Net worth: - $ as of 30/08/2026
Net worth: - $ as of 30/08/2026
Ms. Nicole Lemerond, CFA, is an Independent Director at MediciNova, Inc., an Independent Director at GeoVax Labs, Inc. and an Independent Director at InMed Pharmaceuticals, Inc. She is on the Board of Directors at MediciNova, Inc., GeoVax Labs, Inc. and InMed Pharmaceuticals, Inc. Ms. Lemerond was previously employed as a Managing Partner by NV Capital Management.
She received her undergraduate degree from Cornell University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MEDICINOVA, INC. -.--% | 22/06/2026 | 0 ( -.--% ) | - $ | 30/08/2026 |
GEOVAX LABS, INC. -.--% | 27/08/2026 | 0 ( -.--% ) | - $ | 30/08/2026 |
| 18/12/2025 | 0 ( -.--% ) | - $ | 30/08/2026 |
| Companies | Position | Start |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Director/Board Member | 07/08/2022 |
| GEOVAX LABS, INC. | Director/Board Member | 30/08/2022 |
| MEDICINOVA, INC. | Director/Board Member | 03/08/2023 |
| Companies | Position | End |
|---|---|---|
NV Capital Management | Corporate Officer/Principal | 31/07/2022 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
MediciNova, Inc.
MediciNova, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops novel therapeutics for the treatment of neurological and other disorders | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeoVax Labs, Inc.
GeoVax Labs, Inc. BiotechnologyHealth Technology Develops vaccines for diseases caused by Human Immunodeficiency Virus and other infectious agents | Health Technology |
NV Capital Management |
Select your edition
All financial news and data tailored to specific country editions